Skip to main content
. Author manuscript; available in PMC: 2010 Oct 15.
Published in final edited form as: Anticancer Res. 2009 Oct;29(10):3769–3775.

Figure 4.

Figure 4

Expression of cyclin D1 (A) and cyclin B1 (B), and Rb (C) in the presence of celecoxib (0–25 μM). Minimal variation in cyclin expression in the high-grade, COX-2–null cell line UM-UC-3 is observed as compared with the low-grade, COX-2 expressor RT-4.